ECMO

Extracorporeal Membrane Oxygenation (एक्मो (ECMO)) is a highly advanced life-support treatment used when a patient’s heart or lungs become so weak that they can no longer function properly even with the best possible medicines, ventilators, or life-support machines.

You can think of एक्मो (ECMO) as a temporary artificial heart and artificial lung. It takes over the work of these organs from outside the body, giving them time to rest, heal, and recover. In many cases, एक्मो (ECMO) also buys time until the patient becomes fit for a major heart/lung surgery or even an organ transplant. Sometimes एक्मो (ECMO) is also used to support the heart after an open heart operation till it gains power to support the circulation of the body.

एक्मो (ECMO) continuously oxygenates the blood and removes carbon dioxide—just like healthy heart and lungs do—helping protect vital organs during critical illness.

How Does ECMO Work?

To understand एक्मो (ECMO), imagine a simple loop:

  1. Blood is taken out of the body using soft tubes (cannulas).

  2. It enters an external oxygenator that works like an artificial lung, removing carbon dioxide and adding fresh oxygen.

  3. The oxygen-rich blood is then pumped back into the patient’s body.

This cycle runs continuously and safely, allowing the patient’s heart and lungs to rest while still supplying oxygen to the brain, kidneys, liver, and other vital organs.

The एक्मो (ECMO) system includes:

  • Pump– Works like an artificial heart, pumping the blood throughout the body.

  • Oxygenator– Acts as an artificial lung, adding oxygen and removing carbon dioxide.

  • Cannulas and Tubing– Special tubes that connect the patient to the एक्मो (ECMO) machine.

  • Heater– Warms the blood to body temperature before returning it to the patient.

Together, these components keep the body alive and stable even when the heart and lungs are extremely weak.

How एक्मो (ECMO) Is Similar to a Heart–Lung Machine, and How It Is Different

एक्मो (ECMO) and the heart–lung machine used during open-heart surgery are similar because both take over the work of the heart and lungs from outside the body. Both:

  • Add oxygen to the blood

  • Remove carbon dioxide

  • Maintain blood circulation

However, they differ in important ways:

How they differ:

  • heart–lung machine is used only during open-heart surgery, typically for 2–6 hours.

  • एक्मो (ECMO) can support life for days to weeks, sometimes months.

  • A heart–lung machine is used when the chest is surgically open, while एक्मो (ECMO) can also work with the chest closed, using cannulas placed in the neck or groin.

  • एक्मो (ECMO) provides gentler, long-term support, whereas a heart–lung machine provides high-flow short-term support.

  • एक्मो (ECMO) allows the heart and lungs to recover over time, while the heart–lung machine temporarily replaces their function during surgery.

In simple words:
A heart–lung machine supports the body during surgery. एक्मो (ECMO) supports the body during life-threatening illness.

Types of एक्मो (ECMO)

  1. Veno-Arterial एक्मो (ECMO) (VA-एक्मो (ECMO))
    Supports both the heart and the lungs.

    • Blood is removed from a vein and returned into an artery.

    • Used when the heart is failing or unable to pump blood.

    • Common situations: cardiogenic shockcardiac arrestsevere heart failure.

  1. Veno-Venous एक्मो (ECMO) (VV-एक्मो (ECMO))
    Supports only the lungs.

    • Blood is taken from a vein and returned to a vein.

    • Used for severe lung damage when the heart is functioning normally.

    • Situations: ARDS, severe pneumoniaCOVID-19 lung failuretrauma.

When Is एक्मो (ECMO) Used?

एक्मो (ECMO) is a last-resort, life-saving therapy, used only when standard treatments like ventilators and medicines are unable to maintain adequate oxygen levels.
Situations where एक्मो (ECMO) may be required:

  • Severe heart failure unresponsive to treatment

  • Cardiac arrest requiring circulatory support

  • Severe respiratory failure due to pneumonia, ARDS, trauma, or COVID-19

  • As a bridge to heart or lung transplant (to sustain life till a donor heart or lung is available for transplant)

  • Post-cardiac surgery support when the heart needs rest

  • Massive pulmonary embolism

  • Cardiogenic shock

  • Some poisoning cases (e.g. Sulphas poisoning)

In these conditions, एक्मो (ECMO) gives time for the treating team to stabilize the patient and manage the underlying disease.

Procedure Overview

  1. Cannulation
    Large, flexible tubes are inserted into major blood vessels (neck or groin) under anesthesia or sedation in a sterile, monitored environment.

  1. एक्मो (ECMO) Connection
    The एक्मो (ECMO) machine is connected, and it begins supporting the patient by oxygenating blood and helping circulate it.

  1. Continuous Monitoring
    A dedicated एक्मो (ECMO) team supervises the patient 24/7, monitoring:

    • Oxygen levels

    • Blood pressure

    • Heart rate

    • Blood clotting levels

    • एक्मो (ECMO) circuit performance

    This ensures early detection of any changes and rapid adjustments.

  1. Weaning and Removal
    As the heart or lungs recover, एक्मो (ECMO) support is slowly reduced.
    If the patient maintains stability, the machine is disconnected, and the cannulas are removed.

Benefits of एक्मो (ECMO)

  • Provides life-saving support during critical heart or lung failure

  • Gives organs time to rest, heal, and recover

  • Improves oxygenation when ventilators are insufficient

  • Helps reverse organ damage caused by low oxygen

  • Allows doctors to treat the underlying illness while the machine maintains vital functions

एक्मो (ECMO) has significantly improved survival in patients who earlier had extremely limited chances of recovery.

Risks and Complications

Although एक्मो (ECMO) is highly effective, it is a complex procedure and carries certain risks:

  • Bleeding, due to blood-thinning medications

  • Infection at cannula sites

  • Blood clots in the एक्मो (ECMO) tubing

  • Kidney dysfunction

  • Liver dysfunction

  • Stroke or embolism

  • Reduced blood flow to limbs (ischemia)

These risks are minimized with strict protocols, advanced monitoring, and expert ICU and एक्मो (ECMO) teams.

Recovery and Post-एक्मो (ECMO) Care

After एक्मो (ECMO), patients may need additional supportive care as their organs gradually regain strength. This may include:

  • Ventilator support for lung recovery

  • Cardiac rehabilitation and continuous heart monitoring

  • Physiotherapy to restore muscle strength

  • Nutritional support to aid healing

  • Psychological support to cope with the stress of critical illness

Many patients show steady improvement over days to weeks after एक्मो (ECMO) removal.

एक्मो (ECMO) in Modern Medicine

एक्मो (ECMO) has become a crucial part of advanced critical care worldwide.
During the COVID-19 pandemic, it played a key role in saving patients with severe respiratory failure.

Most leading hospitals now have:

  • Dedicated एक्मो (ECMO) units

  • Specialized intensivists, perfusionists, and nursing teams

  • 24/7 monitoring systems

  • Advanced protocols for safety and outcomes

As technology continues to improve, एक्मो (ECMO) remains a powerful tool for treating the sickest of patients.

Frequently Asked Questions

Is एक्मो (ECMO) a permanent treatment?

No. एक्मो (ECMO) is a temporary life-support method used only until the heart or lungs recover or until the patient undergoes surgery or a transplant.

It varies. Some patients need एक्मो (ECMO) for a few days, while others may require it for several weeks, depending on recovery.

No. Patients are usually kept sedated and comfortable. The machine works outside the body, so the patient does not feel it.

एक्मो (ECMO) itself does not cure the disease.
It keeps the patient alive while doctors treat the root cause and while the organs recover.

No. It requires highly trained specialists and advanced equipment.
Only specialized centers with experienced एक्मो (ECMO) teams offer this therapy.

Survival depends on the patient’s condition, age, underlying illness, and response to treatment.
एक्मो (ECMO) has significantly improved survival rates in critically ill patients.